25 XP   0   0   10

Capstone Therapeutics Corp
Buy, Hold or Sell?

Let's analyse Capstone Therapeutics Corp together

PenkeI guess you are interested in Capstone Therapeutics Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Capstone Therapeutics Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Capstone Therapeutics Corp

I send you an email if I find something interesting about Capstone Therapeutics Corp.

Quick analysis of Capstone Therapeutics Corp (30 sec.)










What can you expect buying and holding a share of Capstone Therapeutics Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$15.46
Expected worth in 1 year
$-20.93
How sure are you?
28.2%

+ What do you gain per year?

Total Gains per Share
$-36.39
Return On Investment
-699.8%

For what price can you sell your share?

Current Price per Share
$5.20
Expected price per share
$5.2 - $5.2
How sure are you?
50%

1. Valuation of Capstone Therapeutics Corp (5 min.)




Live pricePrice per Share (EOD)

$5.20

Intrinsic Value Per Share

$130.40 - $156.44

Total Value Per Share

$145.86 - $171.91

2. Growth of Capstone Therapeutics Corp (5 min.)




Is Capstone Therapeutics Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$2.4m$25.8m-$21.4m-486.1%

How much money is Capstone Therapeutics Corp making?

Current yearPrevious yearGrowGrow %
Making money-$954.7k$578.7k-$1.5m-160.6%
Net Profit Margin-9.1%2.6%--

How much money comes from the company's main activities?

3. Financial Health of Capstone Therapeutics Corp (5 min.)




4. Comparing to competitors in the Building Materials industry (5 min.)




  Industry Rankings (Building Materials)  

What can you expect buying and holding a share of Capstone Therapeutics Corp? (5 min.)

Welcome investor! Capstone Therapeutics Corp's management wants to use your money to grow the business. In return you get a share of Capstone Therapeutics Corp.

What can you expect buying and holding a share of Capstone Therapeutics Corp?

First you should know what it really means to hold a share of Capstone Therapeutics Corp. And how you can make/lose money.

Speculation

The Price per Share of Capstone Therapeutics Corp is $5.2. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Capstone Therapeutics Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Capstone Therapeutics Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $15.46. Based on the TTM, the Book Value Change Per Share is $-9.10 per quarter. Based on the YOY, the Book Value Change Per Share is $-33.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Capstone Therapeutics Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-12.81-246.3%-6.06-116.5%3.6770.6%3.4365.9%1.4327.4%
Usd Book Value Change Per Share-8.13-156.4%-9.10-174.9%-33.16-637.7%1.1722.5%-0.78-15.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-8.13-156.4%-9.10-174.9%-33.16-637.7%1.1722.5%-0.78-15.0%
Usd Price Per Share5.20-14.43-36.50-21.26-10.96-
Price to Earnings Ratio-0.10--1.50--2.15--0.97--0.50-
Price-to-Total Gains Ratio-0.64--1.43--6.11--0.86--0.45-
Price to Book Ratio0.34-0.46-0.31-0.07-0.03-
Price-to-Total Gains Ratio-0.64--1.43--6.11--0.86--0.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.2
Number of shares192
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-9.101.17
Usd Total Gains Per Share-9.101.17
Gains per Quarter (192 shares)-1,746.59224.21
Gains per Year (192 shares)-6,986.36896.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-6986-69960897887
20-13973-13982017941784
30-20959-20968026912681
40-27945-27954035873578
50-34932-34940044844475
60-41918-41926053815372
70-48905-48912062786269
80-55891-55898071757166
90-62877-62884080728063
100-69864-69870089688960

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%5.07.00.041.7%8.012.00.040.0%10.020.09.025.6%23.020.052.024.2%
Book Value Change Per Share0.04.00.00.0%5.07.00.041.7%8.012.00.040.0%11.028.00.028.2%25.070.00.026.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.039.00.0%0.00.095.00.0%
Total Gains per Share0.04.00.00.0%5.07.00.041.7%8.012.00.040.0%11.028.00.028.2%25.070.00.026.3%

Fundamentals of Capstone Therapeutics Corp

About Capstone Therapeutics Corp

Capstone Holding Corp., through its subsidiaries, engages in the distribution of masonry stone products in the United States. Its masonry stone products include manufactured and natural stone veneer sidings, hardscapes and related moisture management products, lath products, and fireplaces offered under the Instone and Northeast Masonry names for residential and commercial construction. The company was formerly known as Capstone Therapeutics Corp. and changed its name to Capstone Holding Corp. in February 2022. Capstone Holding Corp. was incorporated in 1987 and is headquartered in Tempe, Arizona. Capstone Holding Corp. operates as a subsidiary of BP Peptides, LLC

Fundamental data was last updated by Penke on 2024-04-20 04:19:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Capstone Therapeutics Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Capstone Therapeutics Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • A Net Profit Margin of -21.3% means that $-0.21 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Capstone Therapeutics Corp:

  • The MRQ is -21.3%. The company is making a huge loss. -2
  • The TTM is -9.1%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-21.3%TTM-9.1%-12.2%
TTM-9.1%YOY2.6%-11.7%
TTM-9.1%5Y3.3%-12.4%
5Y3.3%10Y3.3%0.0%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.3%4.4%-25.7%
TTM-9.1%5.4%-14.5%
YOY2.6%6.4%-3.8%
5Y3.3%5.9%-2.6%
10Y3.3%5.7%-2.4%
1.1.2. Return on Assets

Shows how efficient Capstone Therapeutics Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • -3.8% Return on Assets means that Capstone Therapeutics Corp generated $-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Capstone Therapeutics Corp:

  • The MRQ is -3.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.8%TTM-1.6%-2.2%
TTM-1.6%YOY0.8%-2.4%
TTM-1.6%5Y-25.0%+23.3%
5Y-25.0%10Y-18.0%-7.0%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.8%1.5%-5.3%
TTM-1.6%1.5%-3.1%
YOY0.8%1.9%-1.1%
5Y-25.0%1.8%-26.8%
10Y-18.0%1.9%-19.9%
1.1.3. Return on Equity

Shows how efficient Capstone Therapeutics Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • -82.8% Return on Equity means Capstone Therapeutics Corp generated $-0.83 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Capstone Therapeutics Corp:

  • The MRQ is -82.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -29.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-82.8%TTM-29.7%-53.2%
TTM-29.7%YOY0.6%-30.3%
TTM-29.7%5Y2.1%-31.8%
5Y2.1%10Y6.3%-4.1%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-82.8%2.7%-85.5%
TTM-29.7%2.8%-32.5%
YOY0.6%3.7%-3.1%
5Y2.1%3.6%-1.5%
10Y6.3%3.2%+3.1%

1.2. Operating Efficiency of Capstone Therapeutics Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Capstone Therapeutics Corp is operating .

  • Measures how much profit Capstone Therapeutics Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Capstone Therapeutics Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y0.9%-0.9%
5Y0.9%10Y2.2%-1.3%
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.9%-9.9%
TTM-6.7%-6.7%
YOY-10.4%-10.4%
5Y0.9%9.8%-8.9%
10Y2.2%8.8%-6.6%
1.2.2. Operating Ratio

Measures how efficient Capstone Therapeutics Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Building Materials industry mean).
  • An Operation Ratio of 1.97 means that the operating costs are $1.97 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 1.973. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.841. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.973TTM1.841+0.132
TTM1.841YOY1.675+0.166
TTM1.8415Y1.303+0.538
5Y1.30310Y0.680+0.623
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9731.589+0.384
TTM1.8411.546+0.295
YOY1.6751.394+0.281
5Y1.3031.372-0.069
10Y0.6801.197-0.517

1.3. Liquidity of Capstone Therapeutics Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Capstone Therapeutics Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Building Materials industry mean).
  • A Current Ratio of 1.14 means the company has $1.14 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 1.142. The company is just able to pay all its short-term debts.
  • The TTM is 1.329. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.142TTM1.329-0.188
TTM1.329YOY1.406-0.077
TTM1.3295Y1.204+0.125
5Y1.20410Y1.764-0.560
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1421.502-0.360
TTM1.3291.513-0.184
YOY1.4061.475-0.069
5Y1.2041.553-0.349
10Y1.7641.396+0.368
1.3.2. Quick Ratio

Measures if Capstone Therapeutics Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • A Quick Ratio of 0.17 means the company can pay off $0.17 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 0.172. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.288. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.172TTM0.288-0.115
TTM0.288YOY0.327-0.039
TTM0.2885Y0.291-0.003
5Y0.29110Y0.155+0.136
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1720.679-0.507
TTM0.2880.706-0.418
YOY0.3270.774-0.447
5Y0.2910.822-0.531
10Y0.1550.805-0.650

1.4. Solvency of Capstone Therapeutics Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Capstone Therapeutics Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Capstone Therapeutics Corp to Building Materials industry mean.
  • A Debt to Asset Ratio of 0.95 means that Capstone Therapeutics Corp assets are financed with 95.4% credit (debt) and the remaining percentage (100% - 95.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 0.954. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.931. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.954TTM0.931+0.023
TTM0.931YOY0.631+0.300
TTM0.9315Y3.644-2.714
5Y3.64410Y2.340+1.304
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9540.437+0.517
TTM0.9310.440+0.491
YOY0.6310.446+0.185
5Y3.6440.461+3.183
10Y2.3400.459+1.881
1.4.2. Debt to Equity Ratio

Measures if Capstone Therapeutics Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • A Debt to Equity ratio of 2,062.5% means that company has $20.63 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Capstone Therapeutics Corp:

  • The MRQ is 20.625. The company is unable to pay all its debts with equity. -1
  • The TTM is 14.486. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ20.625TTM14.486+6.140
TTM14.486YOY2.669+11.817
TTM14.4865Y4.089+10.396
5Y4.08910Y2.803+1.286
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
MRQ20.6250.897+19.728
TTM14.4860.908+13.578
YOY2.6690.882+1.787
5Y4.0890.962+3.127
10Y2.8031.008+1.795

2. Market Valuation of Capstone Therapeutics Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Capstone Therapeutics Corp generates.

  • Above 15 is considered overpriced but always compare Capstone Therapeutics Corp to the Building Materials industry mean.
  • A PE ratio of -0.10 means the investor is paying $-0.10 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Capstone Therapeutics Corp:

  • The EOD is -0.101. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.101. Based on the earnings, the company is expensive. -2
  • The TTM is -1.497. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.101MRQ-0.1010.000
MRQ-0.101TTM-1.497+1.396
TTM-1.497YOY-2.151+0.654
TTM-1.4975Y-0.970-0.527
5Y-0.97010Y-0.498-0.472
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD-0.10110.533-10.634
MRQ-0.10111.706-11.807
TTM-1.49712.434-13.931
YOY-2.15111.128-13.279
5Y-0.97014.486-15.456
10Y-0.49819.332-19.830
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Capstone Therapeutics Corp:

  • The EOD is 0.151. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 0.151. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 0.043. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.151MRQ0.1510.000
MRQ0.151TTM0.043+0.108
TTM0.043YOY0.641-0.599
TTM0.0435Y0.088-0.045
5Y0.08810Y0.043+0.045
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD0.1515.471-5.320
MRQ0.1515.972-5.821
TTM0.0436.747-6.704
YOY0.6412.225-1.584
5Y0.0885.493-5.405
10Y0.0434.884-4.841
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Capstone Therapeutics Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Building Materials industry mean).
  • A PB ratio of 0.34 means the investor is paying $0.34 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Capstone Therapeutics Corp:

  • The EOD is 0.336. Based on the equity, the company is cheap. +2
  • The MRQ is 0.336. Based on the equity, the company is cheap. +2
  • The TTM is 0.458. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.336MRQ0.3360.000
MRQ0.336TTM0.458-0.122
TTM0.458YOY0.314+0.144
TTM0.4585Y0.065+0.393
5Y0.06510Y0.033+0.032
Compared to industry (Building Materials)
PeriodCompanyIndustry (mean)+/- 
EOD0.3361.254-0.918
MRQ0.3361.173-0.837
TTM0.4581.115-0.657
YOY0.3141.286-0.972
5Y0.0651.425-1.360
10Y0.0331.542-1.509
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Capstone Therapeutics Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---8.134-9.097+12%-33.159+308%1.168-797%-0.778-90%
Book Value Per Share--15.46227.965-45%163.903-91%70.694-78%38.916-60%
Current Ratio--1.1421.329-14%1.406-19%1.204-5%1.764-35%
Debt To Asset Ratio--0.9540.931+2%0.631+51%3.644-74%2.340-59%
Debt To Equity Ratio--20.62514.486+42%2.669+673%4.089+404%2.803+636%
Dividend Per Share----0%-0%-0%-0%
Eps---12.810-6.058-53%3.672-449%3.425-474%1.426-998%
Free Cash Flow Per Share--8.6161.968+338%-4.859+156%-0.099+101%-0.489+106%
Free Cash Flow To Equity Per Share---0.1970.044-543%-0.043-78%-0.486+147%1.365-114%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.769+30%
Intrinsic Value_10Y_max--156.445--------
Intrinsic Value_10Y_min--130.401--------
Intrinsic Value_1Y_max--3.593--------
Intrinsic Value_1Y_min--3.522--------
Intrinsic Value_3Y_max--20.005--------
Intrinsic Value_3Y_min--18.912--------
Intrinsic Value_5Y_max--47.519--------
Intrinsic Value_5Y_min--43.313--------
Market Cap819572.0000%819572.0002273524.250-64%5752765.000-86%3350038.376-76%1727154.232-53%
Net Profit Margin---0.213-0.091-57%0.026-931%0.033-744%0.033-739%
Operating Margin----0%-0%0.009-100%0.022-100%
Operating Ratio--1.9731.841+7%1.675+18%1.303+51%0.680+190%
Pb Ratio0.3360%0.3360.458-27%0.314+7%0.065+415%0.033+911%
Pe Ratio-0.1010%-0.101-1.497+1375%-2.151+2020%-0.970+856%-0.498+391%
Price Per Share5.2000%5.20014.425-64%36.500-86%21.255-76%10.958-53%
Price To Free Cash Flow Ratio0.1510%0.1510.043+253%0.641-76%0.088+72%0.043+249%
Price To Total Gains Ratio-0.6390%-0.639-1.430+124%-6.106+855%-0.856+34%-0.450-30%
Quick Ratio--0.1720.288-40%0.327-47%0.291-41%0.155+11%
Return On Assets---0.038-0.016-57%0.008-582%-0.250+552%-0.180+370%
Return On Equity---0.828-0.297-64%0.006-13299%0.021-3963%0.063-1423%
Total Gains Per Share---8.134-9.097+12%-33.159+308%1.168-797%-0.778-90%
Usd Book Value--2437000.0004407500.000-45%25832750.000-91%11142150.000-78%6133589.744-60%
Usd Book Value Change Per Share---8.134-9.097+12%-33.159+308%1.168-797%-0.778-90%
Usd Book Value Per Share--15.46227.965-45%163.903-91%70.694-78%38.916-60%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---12.810-6.058-53%3.672-449%3.425-474%1.426-998%
Usd Free Cash Flow--1358000.000310250.000+338%-765750.000+156%-15550.000+101%-57307.692+104%
Usd Free Cash Flow Per Share--8.6161.968+338%-4.859+156%-0.099+101%-0.489+106%
Usd Free Cash Flow To Equity Per Share---0.1970.044-543%-0.043-78%-0.486+147%1.365-114%
Usd Market Cap819572.0000%819572.0002273524.250-64%5752765.000-86%3350038.376-76%1727154.232-53%
Usd Price Per Share5.2000%5.20014.425-64%36.500-86%21.255-76%10.958-53%
Usd Profit---2019000.000-954750.000-53%578750.000-449%539850.000-474%224820.513-998%
Usd Revenue--9485000.00012088500.000-22%15395000.000-38%11106400.000-15%5746871.795+65%
Usd Total Gains Per Share---8.134-9.097+12%-33.159+308%1.168-797%-0.778-90%
 EOD+0 -0MRQTTM+10 -22YOY+10 -225Y+9 -2410Y+9 -25

3.2. Fundamental Score

Let's check the fundamental score of Capstone Therapeutics Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.101
Price to Book Ratio (EOD)Between0-10.336
Net Profit Margin (MRQ)Greater than0-0.213
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.172
Current Ratio (MRQ)Greater than11.142
Debt to Asset Ratio (MRQ)Less than10.954
Debt to Equity Ratio (MRQ)Less than120.625
Return on Equity (MRQ)Greater than0.15-0.828
Return on Assets (MRQ)Greater than0.05-0.038
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Capstone Therapeutics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 505.200
Ma 50Greater thanMa 1005.200
Ma 100Greater thanMa 2005.200
OpenGreater thanClose5.200
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets52,701
Total Liabilities50,264
Total Stockholder Equity2,437
 As reported
Total Liabilities 50,264
Total Stockholder Equity+ 2,437
Total Assets = 52,701

Assets

Total Assets52,701
Total Current Assets17,082
Long-term Assets35,619
Total Current Assets
Cash And Cash Equivalents 52
Net Receivables 2,581
Inventory 12,838
Other Current Assets 699
Total Current Assets  (as reported)17,082
Total Current Assets  (calculated)16,170
+/- 912
Long-term Assets
Property Plant Equipment 4,678
Goodwill 23,286
Intangible Assets 10
Long-term Assets Other 48
Long-term Assets  (as reported)35,619
Long-term Assets  (calculated)28,022
+/- 7,597

Liabilities & Shareholders' Equity

Total Current Liabilities14,963
Long-term Liabilities35,301
Total Stockholder Equity2,437
Total Current Liabilities
Short Long Term Debt 11,177
Total Current Liabilities  (as reported)14,963
Total Current Liabilities  (calculated)11,177
+/- 3,786
Long-term Liabilities
Long term Debt 6,123
Capital Lease Obligations Min Short Term Debt3,028
Long-term Liabilities  (as reported)35,301
Long-term Liabilities  (calculated)9,151
+/- 26,150
Total Stockholder Equity
Total Stockholder Equity (as reported)2,437
Total Stockholder Equity (calculated)0
+/- 2,437
Other
Common Stock Shares Outstanding 158
Net Debt 17,248
Net Invested Capital 19,737
Net Working Capital 2,119
Property Plant and Equipment Gross 6,214



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
92,301
93,283
90,331
65,035
63,448
55,547
48,034
49,697
50,256
51,455
52,899
53,420
53,895
54,217
56,679
130,106
128,906
124,547
120,555
115,184
108,830
103,368
95,497
88,343
85,487
78,827
75,021
72,589
68,719
65,785
63,904
61,862
58,674
55,436
52,500
49,514
44,836
42,289
39,671
37,135
33,823
30,779
27,871
25,288
22,329
19,992
18,004
14,696
13,785
13,058
12,732
11,591
10,460
9,229
8,133
7,317
6,511
5,283
4,093
3,385
2,798
2,134
1,546
1,767
1,413
1,200
1,597
1,182
882
758
2,037
1,569
1,038
2,420
1,962
1,477
1,221
703
208
284
191
41,276
41,479
54,874
65,909
64,212
66,411
64,068
69,181
73,340
68,986
65,212
67,171
65,697
63,322
52,701
52,70163,32265,69767,17165,21268,98673,34069,18164,06866,41164,21265,90954,87441,47941,2761912842087031,2211,4771,9622,4201,0381,5692,0377588821,1821,5971,2001,4131,7671,5462,1342,7983,3854,0935,2836,5117,3178,1339,22910,46011,59112,73213,05813,78514,69618,00419,99222,32925,28827,87130,77933,82337,13539,67142,28944,83649,51452,50055,43658,67461,86263,90465,78568,71972,58975,02178,82785,48788,34395,497103,368108,830115,184120,555124,547128,906130,10656,67954,21753,89553,42052,89951,45550,25649,69748,03455,54763,44865,03590,33193,28392,301
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
829
568
484
1,802
1,373
881
2,302
1,884
1,438
1,221
703
284
284
191
16,859
16,979
16,029
19,523
18,093
21,091
18,486
23,847
28,188
23,978
20,972
23,097
21,638
19,542
17,082
17,08219,54221,63823,09720,97223,97828,18823,84718,48621,09118,09319,52316,02916,97916,8591912842847031,2211,4381,8842,3028811,3731,8024845688290000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,896
14,295
18,183
20,943
6,063
7,348
7,162
23,088
20,620
14,731
15,047
12,874
14,280
9,131
11,693
24,387
21,640
19,608
17,608
13,778
13,117
12,824
11,355
10,205
9,201
8,123
7,183
6,258
5,490
4,193
3,111
2,164
1,540
1,037
637
1,011
718
692
1,127
748
486
437
1,718
1,275
805
2,291
1,816
1,341
1,092
305
38
58
37
236
337
0
136
315
256
50
236
262
197
23
68
110
82
52
528211068231972622365025631513603372363758383051,0921,3411,8162,2918051,2751,7184374867481,1276927181,0116371,0371,5402,1643,1114,1935,4906,2587,1838,1239,20110,20511,35512,82413,11713,77817,60819,60821,64024,38711,6939,13114,28012,87415,04714,73120,62023,0887,1627,3486,06320,94318,18314,29519,8960000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,266
23,858
17,157
18,236
35,791
33,660
39,322
22,675
22,959
26,347
23,647
22,268
18,559
20,873
15,467
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000000000000000000000000015,46720,87318,55922,26823,64726,34722,95922,67539,32233,66035,79118,23617,15723,85824,2660000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46
4
0
0
0
0
0
0
0
7,222
7,473
4,055
6,173
6,135
7,979
3,954
6,961
7,827
6,048
3,031
5,577
5,335
4,198
2,581
2,5814,1985,3355,5773,0316,0487,8276,9613,9547,9796,1356,1734,0557,4737,2220000000446000000000000000000000000000000000000000000000000000000000000000000000000
       Other Current Assets 
3,764
3,865
3,465
3,650
4,167
15,625
3,455
3,318
3,342
3,453
3,457
2,265
2,344
2,121
2,262
882
1,089
1,168
302
1,019
1,104
1,470
1,068
857
756
546
480
1,950
1,048
1,160
903
906
1,022
1,140
1,142
1,094
853
835
630
1,660
653
471
419
643
463
170
209
758
532
200
330
383
305
197
83
233
235
345
277
357
291
129
218
109
66
50
31
25
82
47
84
98
30
7
68
97
129
398
267
267
85
368
435
459
1,365
1,388
1,366
321
1,367
1,062
362
520
490
448
503
699
6995034484905203621,0621,3673211,3661,3881,3654594353688526726739812997687309884478225315066109218129291357277345235233831973053833302005327582091704636434194716531,6606308358531,0941,1421,1401,0229069031,1601,0481,9504805467568571,0681,4701,1041,0193021,1681,0898822,2622,1212,3442,2653,4573,4533,3423,3183,45515,6254,1673,6503,4653,8653,764
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,417
24,500
38,845
46,386
46,119
45,320
45,582
45,334
45,152
45,008
44,240
44,074
44,059
43,780
35,619
35,61943,78044,05944,07444,24045,00845,15245,33445,58245,32046,11946,38638,84524,50024,417000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
12,823
12,420
11,900
11,094
11,243
2,092
2,050
1,902
1,832
1,753
1,615
1,498
1,426
1,329
1,245
560
528
479
495
478
424
458
551
525
593
512
403
409
402
369
360
318
339
318
366
436
404
376
347
333
331
304
292
258
226
214
187
160
136
34
28
23
13
7
5
3
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,358
5,254
5,092
5,080
4,804
4,678
4,6784,8045,0805,0925,2545,3580000000000000000000000000000000002357132328341361601872142262582923043313333473764044363663183393183603694024094035125935255514584244784954795285601,2451,3291,4261,4981,6151,7531,8321,9022,0502,09211,24311,09411,90012,42012,823
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,286
23,286
23,286
23,28623,28623,286000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,000
8,000
8,000
8,000
8,000
8,000
8,000
8,000
8,000
8,000
8,000
0
08,0008,0008,0008,0008,0008,0008,0008,0008,0008,0008,000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,142
2,142
2,142
2,351
2,288
2,223
2,240
2,170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,019
980
941
902
862
823
784
745
705
666
627
588
549
509
470
431
392
353
314
274
235
196
157
118
78
39
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
13
10
1013160000000000000000039781181571962352743143533924314705095495886276667057457848238629029419801,0190000000000000000000000002,1702,2402,2232,2882,3512,1422,1422,142000000000000000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
48
156
378
39
48
48
48
48
48
48
48
48
48
48
48
48484848484848484848483937815648000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
8,228
8,694
8,926
9,885
8,067
14,860
6,707
7,201
6,273
6,209
6,255
5,187
5,263
4,989
6,563
6,131
4,404
4,115
4,711
4,254
3,399
4,503
4,225
4,165
4,179
3,380
3,329
3,441
2,452
1,535
1,842
2,401
1,928
2,081
2,373
1,992
1,382
1,853
2,449
2,407
1,963
1,769
1,408
1,816
1,745
1,162
764
119
156
93
214
294
334
101
206
100
288
430
471
282
365
351
188
1,261
1,266
1,431
1,369
1,304
1,391
1,473
2,352
2,448
2,502
2,602
2,832
2,721
3,316
3,463
3,277
4,226
4,416
45,381
44,999
49,066
37,889
33,828
34,102
34,991
40,287
40,884
35,177
57,040
60,971
60,423
59,603
50,264
50,26459,60360,42360,97157,04035,17740,88440,28734,99134,10233,82837,88949,06644,99945,3814,4164,2263,2773,4633,3162,7212,8322,6022,5022,4482,3521,4731,3911,3041,3691,4311,2661,261188351365282471430288100206101334294214931561197641,1621,7451,8161,4081,7691,9632,4072,4491,8531,3821,9922,3732,0811,9282,4011,8421,5352,4523,4413,3293,3804,1794,1654,2254,5033,3994,2544,7114,1154,4046,1316,5634,9895,2635,1876,2556,2096,2737,2016,70714,8608,0679,8858,9268,6948,228
   > Total Current Liabilities 
8,038
8,509
8,759
9,797
7,962
14,719
6,531
6,914
5,970
5,890
5,919
4,835
4,929
4,673
6,265
5,851
4,142
3,942
4,556
4,117
3,280
4,228
3,994
3,982
3,725
2,968
2,957
3,441
2,452
1,535
1,842
2,401
1,928
2,081
2,373
1,992
1,382
1,853
2,449
2,407
1,963
1,769
1,408
1,816
1,745
1,162
764
119
156
93
214
294
334
101
206
100
288
430
471
282
365
351
188
261
266
431
369
304
391
1,473
193
199
206
247
417
246
732
819
1,155
1,155
1,105
12,890
11,722
11,037
14,854
12,820
13,811
12,393
19,589
22,552
17,204
11,888
16,580
15,466
14,125
14,963
14,96314,12515,46616,58011,88817,20422,55219,58912,39313,81112,82014,85411,03711,72212,8901,1051,1551,1558197322464172472061991931,473391304369431266261188351365282471430288100206101334294214931561197641,1621,7451,8161,4081,7691,9632,4072,4491,8531,3821,9922,3732,0811,9282,4011,8421,5352,4523,4412,9572,9683,7253,9823,9944,2283,2804,1174,5563,9424,1425,8516,2654,6734,9294,8355,9195,8905,9706,9146,53114,7197,9629,7978,7598,5098,038
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
2,159
2,249
2,296
2,355
0
0
28
0
2,906
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000002,906028002,3552,2962,2492,1591,000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
2,159
2,249
2,296
2,355
0
0
28
0
2,906
0
0
6,213
4,131
6,441
9,210
8,866
8,190
5,710
10,209
9,969
13,131
8,365
11,939
10,840
10,401
11,177
11,17710,40110,84011,9398,36513,1319,96910,2095,7108,1908,8669,2106,4414,1316,213002,906028002,3552,2962,2492,1591,000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
2,443
2,644
3,545
3,030
2,189
2,973
721
1,031
1,277
1,307
1,292
477
692
703
988
201
665
649
707
833
501
1,243
1,315
1,036
1,516
785
852
1,621
1,045
420
608
702
662
714
905
1,063
651
995
727
719
382
562
392
246
632
385
337
77
144
81
209
233
313
74
200
88
253
112
225
124
185
211
132
254
173
402
325
249
324
393
157
197
203
244
415
245
630
797
379
379
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000379379797630245415244203197157393324249325402173254132211185124225112253882007431323320981144773373856322463925623827197279956511,0639057146627026084201,0451,6218527851,5161,0361,3151,2435018337076496652019887036924771,2921,3071,2771,0317212,9732,1893,0303,5452,6442,443
       Other Current Liabilities 
5,595
5,865
5,214
6,767
5,773
11,746
5,810
5,883
4,693
4,583
4,627
4,358
4,237
3,970
5,277
2,726
2,331
3,200
3,792
3,170
2,699
2,985
2,679
2,946
2,209
2,183
2,105
1,820
1,407
1,115
1,234
1,699
1,266
1,367
1,468
929
731
858
1,722
1,688
1,581
1,207
1,016
1,570
1,113
777
427
42
12
12
5
61
21
27
6
12
35
318
246
158
180
140
56
7
93
29
44
55
67
80
36
2
3
3
2
0
0
0
776
776
811
826
836
536
218
427
926
43
43
43
43
0
0
0
0
0
00000434343439264272185368368268117767760002332368067554429937561401801582463183512627216151212424277771,1131,5701,0161,2071,5811,6881,7228587319291,4681,3671,2661,6991,2341,1151,4071,8202,1052,1832,2092,9462,6792,9852,6993,1703,7923,2002,3312,7265,2773,9704,2374,3584,6274,5834,6935,8835,81011,7465,7736,7675,2145,8655,595
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,584
2,644
0
3,071
3,311
32,491
33,277
38,029
23,035
21,008
20,291
22,598
20,698
18,332
17,973
45,152
44,391
44,957
45,478
35,301
35,30145,47844,95744,39145,15217,97318,33220,69822,59820,29121,00823,03538,02933,27732,4913,3113,07102,6442,5840000000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,000
-2,159
-2,249
-2,296
-2,355
0
0
-28
0
-2,906
0
0
0
0
5,091
4,965
4,826
4,633
4,183
4,001
3,816
3,722
3,524
3,351
3,332
3,122
3,028
3,0283,1223,3323,3513,5243,7223,8164,0014,1834,6334,8264,9655,0910000-2,9060-2800-2,355-2,296-2,249-2,159-1,000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56
37
13
586
581
575
0
0
0
0
0
0
0
0
0
000000000575581586133756000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
84,073
84,589
81,405
55,150
55,381
40,687
41,327
42,496
43,983
45,246
46,644
48,233
48,632
49,228
50,116
123,975
124,502
120,432
115,844
110,930
105,431
98,865
91,272
84,178
81,308
75,447
71,692
69,148
66,267
64,250
62,062
59,461
56,746
53,355
50,127
47,522
43,454
40,436
37,222
34,728
31,860
29,010
26,463
23,472
20,584
18,830
17,240
14,577
13,629
12,965
12,041
11,104
10,126
9,128
7,927
7,217
6,223
4,853
3,622
3,103
2,433
1,783
1,358
506
147
0
228
-122
-509
-715
-315
-879
-1,464
-182
-870
-1,244
-2,095
-2,760
-3,069
-3,301
-3,533
-3,413
-2,796
5,808
28,020
30,384
32,309
29,077
28,894
32,456
33,809
8,172
6,200
5,274
3,719
2,437
2,4373,7195,2746,2008,17233,80932,45628,89429,07732,30930,38428,0205,808-2,796-3,413-3,533-3,301-3,069-2,760-2,095-1,244-870-182-1,464-879-315-715-509-12222801475061,3581,7832,4333,1033,6224,8536,2237,2177,9279,12810,12611,10412,04112,96513,62914,57717,24018,83020,58423,47226,46329,01031,86034,72837,22240,43643,45447,52250,12753,35556,74659,46162,06264,25066,26769,14871,69275,44781,30884,17891,27298,865105,431110,930115,844120,432124,502123,97550,11649,22848,63248,23346,64445,24643,98342,49641,32740,68755,38155,15081,40584,58984,073
   Common Stock
15
15
15
15
16
16
16
16
16
16
16
16
16
16
16
16
17
17
19
19
19
19
19
19
20
20
21
21
21
21
21
21
21
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
20
27
27
27
27
27
27
27
27
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000272727272727272720202020202020202020202020202020202020202020202020202020202020202020202020212121212121212020191919191919171716161616161616161616161615151515
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000-1370-137-137-137-137-137-137-137-137-1370000000
   Other Stockholders Equity 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue48,354
Cost of Revenue-38,743
Gross Profit9,6119,611
 
Operating Income (+$)
Gross Profit9,611
Operating Expense-49,610
Operating Income-1,256-39,999
 
Operating Expense (+$)
Research Development0
Selling General Administrative10,867
Selling And Marketing Expenses0
Operating Expense49,61010,867
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1,529
Other Finance Cost-0
Net Interest Income-1,529
 
Pretax Income (+$)
Operating Income-1,256
Net Interest Income-1,529
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,585-456
EBIT - interestExpense = -1,529
-3,819
-2,290
Interest Expense1,529
Earnings Before Interest and Taxes (EBIT)0-2,056
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-3,585
Tax Provision-234
Net Income From Continuing Ops-3,819-3,819
Net Income-3,819
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-8001,529
 

Technical Analysis of Capstone Therapeutics Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Capstone Therapeutics Corp. The general trend of Capstone Therapeutics Corp is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Capstone Therapeutics Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Capstone Therapeutics Corp.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 5.2 < 5.2 < 5.2.

The bearish price targets are: 5.2 > 5.2 > 5.2.

Tweet this
Capstone Therapeutics Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Capstone Therapeutics Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Capstone Therapeutics Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Capstone Therapeutics Corp. The current macd is -0.00060718.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Capstone Therapeutics Corp price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Capstone Therapeutics Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Capstone Therapeutics Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Capstone Therapeutics Corp Daily Moving Average Convergence/Divergence (MACD) ChartCapstone Therapeutics Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Capstone Therapeutics Corp. The current adx is 100.00.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Capstone Therapeutics Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Capstone Therapeutics Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Capstone Therapeutics Corp. The current sar is 5.45363072.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Capstone Therapeutics Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Capstone Therapeutics Corp. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Capstone Therapeutics Corp Daily Relative Strength Index (RSI) ChartCapstone Therapeutics Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Capstone Therapeutics Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Capstone Therapeutics Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Capstone Therapeutics Corp Daily Stochastic Oscillator ChartCapstone Therapeutics Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Capstone Therapeutics Corp. The current cci is -66.66666667.

Capstone Therapeutics Corp Daily Commodity Channel Index (CCI) ChartCapstone Therapeutics Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Capstone Therapeutics Corp. The current cmo is -100.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Capstone Therapeutics Corp Daily Chande Momentum Oscillator (CMO) ChartCapstone Therapeutics Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Capstone Therapeutics Corp. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Capstone Therapeutics Corp Daily Williams %R ChartCapstone Therapeutics Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Capstone Therapeutics Corp.

Capstone Therapeutics Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Capstone Therapeutics Corp. The current atr is 0.00010952.

Capstone Therapeutics Corp Daily Average True Range (ATR) ChartCapstone Therapeutics Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Capstone Therapeutics Corp. The current obv is -3,100.

Capstone Therapeutics Corp Daily On-Balance Volume (OBV) ChartCapstone Therapeutics Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Capstone Therapeutics Corp. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Capstone Therapeutics Corp Daily Money Flow Index (MFI) ChartCapstone Therapeutics Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Capstone Therapeutics Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Capstone Therapeutics Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Capstone Therapeutics Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 505.200
Ma 50Greater thanMa 1005.200
Ma 100Greater thanMa 2005.200
OpenGreater thanClose5.200
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Capstone Therapeutics Corp with someone you think should read this too:
  • Are you bullish or bearish on Capstone Therapeutics Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Capstone Therapeutics Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Capstone Therapeutics Corp

I send you an email if I find something interesting about Capstone Therapeutics Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Capstone Therapeutics Corp.

Receive notifications about Capstone Therapeutics Corp in your mailbox!